(Q48825282)

English

β-asarone and levodopa co-administration increase striatal dopamine level in 6-hydroxydopamine induced rats by modulating P-glycoprotein and tight junction proteins at the blood-brain barrier and promoting levodopa into the brain.

scientific article published on 15 March 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/26991136

β-asarone and levodopa co-administration increase striatal dopamine level in 6-hydroxydopamine induced rats by modulating P-glycoprotein and tight junction proteins at the blood-brain barrier and promoting levodopa into the brain. (English)

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/26991136

blood–brain barrier

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Liping Huang

1

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/26991136

Minzhen Deng

2

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/26991136

Yuping He

3

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/26991136

Shiyao Lu

4

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/26991136

Ruanxin Ma

5

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/26991136

Yongqi Fang

6

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/26991136

publication date

15 March 2016

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/26991136

Clinical and Experimental Pharmacology and Physiology

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/26991136

43

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/26991136

6

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/26991136

634-643

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/26991136

Optimizing levodopa therapy for Parkinson's disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Antiparkinsonian drugs and their neuroprotective effects

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Intranasally applied L-DOPA alleviates parkinsonian symptoms in rats with unilateral nigro-striatal 6-OHDA lesions.

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Classics in chemical neuroscience: levodopa

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Contrasting effects of peripheral decarboxylase inhibitors on plasma activity of aromatic-L-amino acid decarboxylase and semicarbazide-sensitive amine oxidase in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Drug development in Parkinson's disease: from emerging molecules to innovative drug delivery systems

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Levodopa in the treatment of Parkinson's disease: current controversies

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Mathematical insights into the effects of levodopa

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Drug delivery across the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Triggers and effectors of oxidative stress at blood-brain barrier level: relevance for brain ageing and neurodegeneration

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Molecular biology of brain metastasis

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

The reversible increase in tight junction permeability induced by capsaicin is mediated via cofilin-actin cytoskeletal dynamics and decreased level of occludin

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Phosphatase regulation of intercellular junctions

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Interactions of mitochondria with the actin cytoskeleton

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Dynamic rearrangement of F-actin is required to maintain the antitumor effect of trichostatin A

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Markers of cerebral damage during delirium in elderly patients with hip fracture

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Serum S-100beta as a possible marker of blood-brain barrier disruption

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Beta-asarone attenuates neuronal apoptosis induced by Beta amyloid in rat hippocampus

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Reversing P-glycoprotein-mediated multidrug resistance in vitro by α-asarone and β-asarone, bioactive cis-trans isomers from Acorus tatarinowii

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Neuroprotective Effects of β-Asarone Against 6-Hydroxy Dopamine-Induced Parkinsonism via JNK/Bcl-2/Beclin-1 Pathway

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

The blood-brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates--evidence from in vivo neuroimaging studies

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Beta-asarone, a major component of Acorus tatarinowii Schott, attenuates focal cerebral ischemia induced by middle cerebral artery occlusion in rats

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

β-asarone and levodopa co-administration protects against 6-hydroxydopamine-induced damage in parkinsonian rat mesencephalon by regulating autophagy: down-expression Beclin-1 and light chain 3B and up-expression P62.

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Dopa-decarboxylase gene polymorphisms affect the motor response to L-dopa in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

The Temporal Pattern of Changes in Serum Biomarker Levels Reveals Complex and Dynamically Changing Pathologies after Exposure to a Single Low-Intensity Blast in Mice

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Increased cerebral output of free radicals during hypoxia: implications for acute mountain sickness?

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Dynamic of neurochemical alterations in striatum, hippocampus and cortex after the 6-OHDA mesostriatal lesion.

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Beta-asarone attenuates ischemia-reperfusion-induced autophagy in rat brains via modulating JNK, p-JNK, Bcl-2 and Beclin 1.

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

A rapid and simple method for the determination of 3,4-dihydroxyphenylacetic acid, norepinephrine, dopamine, and serotonin in mouse brain homogenate by HPLC with fluorimetric detection.

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Establish a flow cytometric method for quantitative detection of Beclin-1 expression

1 reference

https://api.crossref.org/works/10.1111%2F1440-1681.12570

21 January 2018

Identifiers

10.1111/1440-1681.12570

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/26991136

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/26991136

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48825282&oldid=1238624259"